The impact of altered gravity and vibration on endothelial cells during a parabolic flight

Cellular Physiology and Biochemistry

Volumn 31, Issue 2-3, 2013, Pages 432-451

  Wehland, Markus ^a   Ma, Xiao ^b   Braun, Markus ^c   Hauslage, Jens ^d   Hemmersbach, Ruth ^d   Bauer, Johann ^e   Grosse, Jirka ^f   Infanger, Manfred ^a   Grimm, Daniela ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF BONN   (Germany)

^d GERMAN AEROSPACE CENTER DLR   (Germany)

^e MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^f UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Angiogenesis; Apoptosis; Cell cycle; Cytoskeleton; Endothelial cells; Extracellular matrix; Hypergravity; Microgravity; Parabolic flight; Vibration

Indexed keywords

TUBULIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BIOCHEMISTRY; CELL CULTURE; CELL CYCLE REGULATION; CONTROLLED STUDY; CYTOSKELETON; DISORIENTATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GRAVITY; HUMAN; HUMAN CELL; MICROGRAVITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION; VIBRATION;

EID: 84876007955     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343380     Document Type: Article

References (116)

1. Pearson JD: Normal endothelial cell function. Lupus 2000;9:183-188.
2. Alliegro MC: Pigpen and endothelial cell differentiation. Cell Biol Int 2001;220:2077-2084.
3. Dvorak HF: Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002;20:4368-4380.
4. Schiffrin EL: The endothelium and control of blood vessel function in health and disease. Clin Invest Med 1994;17:602-620.
5. Mantovani A, Bussolino F, Introna M: Cytokine regulation of endothelial cell function: From molecular level to the bedside. Immunol Today 1997;18:231-240.
6. Buravkova L, Romanov Y, Rykova M, Grigorieva O, Merzlikina N: Cell-to-cell interactions in changed gravity: Ground-based and flight experiments. Acta Astronaut 2005;57:67-74.
7. Sangha DS, Han S, Purdy RE: Simulated microgravity upregulates an endothelial vasoconstrictor prostaglandin. J Appl Physiol 2001;91:789-796.
8. Infanger M, Ulbrich C, Baatout S, Wehland M, Kreutz R, Bauer J, Grosse J, Vadrucci S, Cogoli A, Derradji H, Neefs M, Kster S, Spain S, Paul M, Grimm D: Modelled gravitational unloading induced downregulation of endothelin-1 in human endothelial cells. J Cell Biochem 2007;101:1439-1455.
9. Ulbrich C, Westphal K, Baatout S, Wehland M, Bauer J, Flick B, Infanger M, Kreutz R, Vadrucci S, Egli, M, Cogoli, A, Derradji H, Pietsch J, Paul M, Grimm D: Effects of basic fibroblast growth factor on endothelial cells under conditions of simulated microgravity. J Cell Biochem 2008;104:1324-1341.
10. Infanger M, Kossmehl P, Shakibaei M, Baatout S, Witzin A, Grosse J, Bauer J, Cogoli A, Faramarzi S, Derradji H, Neefs M, Paul M, Grimm D: Induction of three-dimensional assembly and increase in apoptosis of human endothelial cells by simulated microgravity: Impact of vascular endothelial growth factor. Apoptosis 2006;11:749-764.
11. Grosse J, Wehland M, Pietsch J, Ma X, Ulbrich C, Schulz H, Saar K, Hbner N, Hauslage J, Hemmersbach R, Braun M, van Loon J, Vagt N, Infanger M, Eilles C, Egli M, Richter P, Baltz T, Einspanier R, Sharbati S, Grimm D: Short-term weightlessness produced by parabolic flight maneuvers altered gene expression patterns in human endothelial cells. FASEB J 2012;26:639-655.
12. Grimm D, Infanger M, Westphal K, Ulbrich C, Pietsch J, Kossmehl P, Vadrucci S, Baatout S, Flick B, Paul M, Bauer J: A delayed type of three-dimensional growth of human endothelial cells under simulated weightlessness. Tissue Eng Part A 2009;15:2267-2275.
13. Grimm D, Bauer J, Ulbrich C, Westphal K, Wehland M, Infanger M, Aleshcheva G, Pietsch J, Gardi M, Beck M, El-Saghire H, de Saint-Georges L, Baatout S: Different responsiveness of endothelial cells to VEGF and bFGF added to culture media under gravity and simulated microgravity. Tissue Eng Part A 2010;16:1559-1573.
14. Grimm D, Wise P, Lebert M, Richter P, Baatout S: How and why does the proteome respond to microgravity? Expert Rev Proteomics 2011;8:13-27.
15. Pietsch J, Bauer J, Egli M, Infanger M, Wise P, Ulbrich C, Grimm D: The effects of weightlessness on the human organism and mammalian cells. Curr Mol Med 2011;11:350-364.
16. Buravkova LB, Romanov YA: The role of cytoskeleton in cell changes under condition of simulated microgravity. Acta Astronaut 2001;48:647-650.
17. Versari S, Villa A, Bradamante S, Maier J: Alterations of the actin cytoskeleton and increased nitric oxide synthesis are common features in human primary endothelial cell response to changes in gravity. Biochem Biophys Acta 2007;1773:1645-1652.
18. Carlsson SI, Bertilaccio MT, Ballabio E, Maier JA: Endothelial stress by gravitational unloading: effects on cell growth and cytoskeletal organization. Biochem Biophys Acta 2003;1642:173-179.
19. Cotrupi S, Ranzani D, Maier, JA: Impact of modeled microgravity on microvascular endothelial cells. Biochem Biophys Acta 2005;1746:163-168.
20. Siamwala JH, Reddy SH, Majumder S, Kolluru GK, Muley A, Sinha S, Chatterjee S: Simulated microgravity perturbs actin polymerization to promote nitric oxide-associated migration in human immortalized Eahy926 cells. Protoplasma 2010;242:3-12.
21. Sumanasekera WK, Zhao L, Ivanova M, Morgan DD, Noisin EL, Keynton RS, Klinge CM: Effect of estradiol and dihydrotestosterone on hypergravity-induced MAPK signaling and occludin expression in human umbilical vein endothelial cells. Cell Tissue Res 2006;324:243-253.
22. Spisni E, Bianco MC, Blasi F, Santi S, Riccio M, Toni M, Griffoni C, Tomasi V: Hypergravity impairs angiogenic response of in vitro cultured human primary endothelial cells. J Gravit Physiol 2002;9:285-286.
23. Ito Y, Kimura T, Ago Y, Nam K, Hiraku K, Miyazaki K, Masuzawa T, Kishida A: Nano-vibration effect on cell adhesion and its shape. Biomed Mater Eng 2011;21:149-158.
24. White CR, Haidekker MA, Stevens HY, Frangos JA: Extracellular signal-regulated kinase activation and endothelin-1 production in human endothelial cells exposed to vibration. J Physiol 2004;55:565-572.
25. Edgell CJ, McDonald CC, Graham JB: Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 1983;80:3734-3737.
26. Ulbrich C, Pietsch J, Grosse J, Wehland M, Schulz H, Saar K, Hbner N, Hauslage J, Hemmersbach R, Braun M, van Loon J, Vagt N, Egli M, Richter P, Einspanier R, Sharbati S, Baltz T, Infanger M, Ma X, Grimm D: Differential gene regulation under altered gravity conditions in follicular thyroid cancer cells: relationship between the extracellular matrix and the cytoskeleton. Cell Physiol Biochem 2011;28:185-198.
27. Schmidt W: Quickly changing acceleration forces (QCAFs) vibration analysis on the A300 ZERO-G. Microgravity Sci Technol 2004;15:42-48.
28. Kossmehl P, Schönberger J, Shakibaei M, Faramarzi S., Kurth E, Habighorst B, von Bauer R, Wehland M, Kreutz R, Infanger M, Schulze-Tanzil G, Paul M, Grimm D: Increase of fibronectin and osteopontin in porcine hearts following ischemia and reperfusion. J Mol Med 2005;83:626-637.
29. Riecke K, Grimm D, Shakibaei M, Kossmehl P, Schulze-Tanzil G, Paul M, Stahlmann R: Low doses of 2,3,7,8-tetrachlorodibenzo- p-dioxin increase transforming growth factor beta and cause myocardial fibrosis in marmosets (Callithrix jacchus). Arch Toxicol 2002;76:360-366.
30. Rothermund L, Kreutz R, Kossmehl P, Fredersdorf S, Shakibaei M, Schulze-Tanzil G, Paul M, Grimm D: Early onset of chondroitin sulfate and osteopontin expression in Angiotensin II-dependent left ventricular hypertrophy. Am J Hypertens 2002;15:644-652.
31. Infanger M, Faramarzi S, Grosse J, Kurth E, Ulbrich C, Bauer J, Wehland M, Kreutz R, Kossmehl P, Paul M, Grimm D: Expression of vascular endothelial growth factor and receptor tyrosine kinases in cardiac ischemia/reperfusion injury. Cardiovasc Pathol 2007;16:291-299.
32. Neisch AL, Fehon RG: Ezrin, Radixin and Moesin: key regulators of membrane-cortex interactions and signaling. Curr Opin Cell Biol 2011;23:377-382.
33. Fehon RG, McClatchey AI, Bretscher A: Organizing the cell cortex: the role of ERM proteins. Nat Rev Mol Cell Biol 2010;11:276-287.
34. Lankes WT, Furthmayr H: Moesin: a member of the protein 4.1-talin-ezrin family of proteins. Proc Natl Acad Sci USA 1991;88:8297-8301.
35. Krieg J, Hunter T: Identification of the two major epidermal growth factor-induced tyrosine phosphorylation sites in the microvillar core protein ezrin. J Biol Chem 1992;267:19258-19265.
36. Turunen O, Wahlström T, Vaheri A: Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol 1994;126:1445-1453.
37. Mackay DJ, Esch F, Furthmayr H, Hall A: Rho- and rac-dependent assembly of focal adhesion complexes and actin filaments in permeabilized fibroblasts: an essential role for ezrin/radixin/moesin proteins. J Cell Biol 1997;138: 27-938.
38. Hirao M, Sato N, Kondo T, Yonemura S, Monden M, Sasaki T, Takai Y, Tsukita S, Tsukita S: Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J Cell Biol 1996;135:37-51.
39. Hatzoglou A, Ader I, Splingard A, Flanders J, Saade E, Leroy I, Traver S, Aresta S, de Gunzburg J: Gem associates with Ezrin and acts via the Rho-GAP protein Gmip to down-regulate the Rho pathway. Mol Biol Cell 2007;18:1242-1252.
40. D'Angelo R, Aresta S, Blangy A, Del Maestro L, Louvard D, Arpin M: Interaction of ezrin with the novel guanine nucleotide exchange factor PLEKHG6 promotes RhoG-dependent apical cytoskeleton rearrangements in epithelial cells. Mol Biol Cell 2007;18:4780-4793.
41. Van Frden D, Johnson K, Segbert C, Bossinger O: The C. elegans ezrin-radixin-moesin protein ERM-1 is necessary for apical junction remodelling and tubulogenesis in the intestine. Dev Biol 2004;272:262-276.
42. Kerman BE, Cheshire AM, Myat MM, Andrew DJ: Ribbon modulates apical membrane during tube elongation through Crumbs and Moesin. Dev Biol 2008;320:278-288.
43. Louvet S, Aghion J, Santa-Maria A, Mangeat P, Maro B: Ezrin becomes restricted to outer cells following asymmetrical division in the preimplantation mouse embryo. Dev Biol 1996;177:568-579.
44. Grimm D, Bauer J, Schoenberger J: Blockade of neoangiogenesis, a new and promising technique to control the growth of malignant tumors and their metastases. Curr Vasc Pharmacol 2009;7:347-357.
45. Ferrara N: Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004;25:581-611.
46. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-1309.
47. Infanger M, Shakibaei M, Kossmehl P, Hollenberg SM, Grosse J, Faramarzi S, Schulze-Tanzil G, Paul M, Grimm D: Intraluminal application of vascular endothelial growth factor enhances healing of microvascular anastomosis in a rat model. J Vasc Res 2005;42:202-213.
48. Infanger M, Schmidt O, Kossmehl P, Grad S, Ertel W, Grimm D: Vascular endothelial growth factor serum level is strongly enhanced after burn injury and correlated with local and general tissue edema. Burns 2004;30:305-311.
49. Infanger M, Grosse J, Westphal K, Leder A, Ulbrich C, Paul M, Grimm D: Vascular endothelial growth factor induces extracellular matrix proteins and osteopontin in the umbilical artery. Ann Vasc Surg 2008;22:273-284.
50. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995;1:1024-1028.
51. Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-687.
52. Wang KX, Denhardt DT: Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev 2008;19:333-345.
53. Laffón A, Garca-Vicua R, Humbra A, Postigo AA, Corb AL, de Landzuri MO, Snchez-Madrid F: Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J Clin Invest 1991;88:546-552.
54. Schoenberger J, Bauer J, Moosbauer J, Eilles C, Grimm D: Innovative strategies in in vivo apoptosis imaging. Curr Med Chem 2008;15:187-194.
55. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS: Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001;107:1055-1061.
56. Standal T, Borset M, Sundan A: Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol 2004;26:179-184.
57. Steller H: Mechanisms and genes of cellular suicide. Science 1995;267:1445-1449.
58. Orrenius S: Apoptosis: molecular mechanisms and implications for human disease. J Intern Med 1995;237:529-536.
59. Ameisen JC: On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ 2002;9:367-393.
60. Kossmehl P, Kurth E, Faramarzi S, Habighorst B, Shakibaei M, Wehland M, Kreutz R, Infanger M, J Danser AH, Grosse J, Paul M, Grimm D: Mechanisms of apoptosis after ischemia and reperfusion: role of the reninangiotensin system. Apoptosis 2006;11:347-358.
61. Grimm D, Wehland M, Pietsch J, Infanger M, Bauer J: Drugs interfering with apoptosis in breast cancer. Curr Pharm Des 2011;17:272-283.
62. Fuentes-Prior P, Salvesen GS: The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 2004;384:201-232.
63. Huerta S, Goulet EJ, Huerta-Yepez S, Livingston EH: Screening and detection of apoptosis. J Surg Res 2007;139:143-156.
64. Fischer U, Jnicke RU, Schulze-Osthoff K: Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 2003;10:76-100.
65. Raynal P, Pollard HB: Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochem Biophys Acta 1994;1197:63-93.
66. Draeger A, Wray S, Babiychuk EB: Domain architecture of the smooth-muscle plasma membrane: regulation by annexins. Biochem J 2005;387:309-314.
67. Raynal P, Hullin F, Ragab-Thomas JM, Fauvel J, Chap H: Annexin 5 as a potential regulator of annexin 1 phosphorylation by protein kinase C. In vitro inhibition compared with quantitative data on annexin distribution in human endothelial cells. Biochem J 1993;292:759-765.
68. Eberhard DA, Vandenberg SR: Annexins I and II bind to lipid A: a possible role in the inhibition of endotoxins. Biochem J 1998;330:67-72.
69. Mayran N, Parton RG, Gruenberg J: Annexin II regulates multivesicular endosome biogenesis in the degradation pathway of animal cells. EMBO J 2003;22:3242-3253.
70. Hayes MJ, Rescher U, Gerke V, Moss SE: Annexin-actin interactions. Traffic 2004;5:571-576.
71. De BK, Misono KS, Lukas TJ, Mroczkowski B, Cohen S: A calcium-dependent 35-kilodalton substrate for epidermal growth factor receptor/kinase isolated from normal tissue. J Biol Chem 1986;261:13784-13792.
72. Croxtall JD, Waheed S, Choudhury Q, Anand R, Flower RJ: N-terminal peptide fragments of lipocortin-1 inhibit A549 cell growth and block EGF-induced stimulation of proliferation. Int J Cancer 1993;54:153-158.
73. Canaider S, Solito E, de Coupade C, Flower RJ, Russo-Marie F, Goulding NJ, Perretti M: Increased apoptosis in U937 cells over-expressing lipocortin 1 (annexin I). Life Sci 2000;66:265-270.
74. Solito E, de Coupade C, Canaider S, Goulding NJ, Perretti M: Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol 2001;133:217-228.
75. Solito E, Kamal A, Russo-Marie F, Buckingham JC, Marullo S, Perretti M: A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J 2003;17:1544-1546.
76. Johnson ME, Howerth EW: Survivin: a bifunctional inhibitor of apoptosis protein. Vet Pathol 2004;41:599-607.
77. Cheung CH, Sun X, Kanwar JR, Bai JZ, Cheng L, Krissansen GW: A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy. Cancer Cell Int 2010;10:36.
78. Kanwar JR, Shen WP, Kanwar RK, Berg RW, Krissansen GW: Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy. J Natl Cancer Inst 2001;93:1541-1552.
79. Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK, Oh BH: An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 2001;40:1117-1113.
80. Liu T, Brouha B, Grossman D: Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene 2004;23:39-48.
81. Murray AW: Recycling the cell cycle: cyclins revisited. Cell 2004;116:221-234.
82. Bloom J, Cross FR: Multiple levels of cyclin specificity in cell-cycle control. Nat Rev Mol Cell Biol 2007;8:149-160.
83. Ravnik SE, Wolgemuth DJ: The developmentally restricted pattern of expression in the male germ line of a murine cyclin A, cyclin A2, suggests roles in both mitotic and meiotic cell cycles. Dev Biol 1996;173:69-78.
84. Sweeney C, Murphy M, Kubelka M, Ravnik SE, Hawkins CF, Wolgemuth DJ, Carrington M: A distinct cyclin A is expressed in germ cells in the mouse. Development 1996;122:53-64.
85. Yang R, Morosetti R, Koeffler HP: Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines. Cancer Res 1997;57:913-920.
86. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G: Cyclin A is required at two points in the human cell cycle. EMBO J 1992;11:9619-9671.
87. Yam CH, Fung TK, Poon RY: Cyclin A in cell cycle control and cancer. Cell Mol Life Sci 2002;59:1317-1326.
88. De Boer L, Oakes V, Beamish H, Giles N, Stevens F, Somodevilla-Torres M, Desouza C, Gabrielli B: Cyclin A/ cdk2 coordinates centrosomal and nuclear mitotic events. Oncogene 2008;27:4261-4268.
89. Sherr CJ: G1 phase progression: cycling on cue. Cell 1994;79:551-555.
90. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA: Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 1995;82:621-630.
91. Freeman RS, Estus S, Johnson EM Jr: Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death. Neuron 1994;12:343-355.
92. Zwijsen RM, Buckle RS, Hijmans EM, Loomans CJ, Bernards R: Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev 1998;2:3488-3498.
93. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995;9:1149-1163.
94. Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13:1501-1512.
95. Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992;71:505-514.
96. Nakanishi M, Adami GR, Robetorye RS, Noda A, Venable SF, Dimitrov D, Pereira-Smith OM, Smith JR: Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. Proc Natl Acad Sci USA 1995;92:4352-4356.
97. Li Y, Jenkins CW, Nichols MA, Xiong Y: Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 1994;9:2261-2268.
98. Zhang Y, Fujita N, Tsuruo T: Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene 1999;18:1131-1138.
99. Jónsson ZO, Hbscher U: Proliferating cell nuclear antigen: more than a clamp for DNA polymerases. Bioessays 1997;19:967-975.
100. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994;211:90-98.
101. Thiel CS, Paulsen K, Bradacs G, Lust K, Tauber S, Dumrese C, Hilliger A, Schoppmann K, Biskup J, Gölz N, Sang C, Ziegler U, Grote KH, Zipp F, Zhuang F, Engelmann F, Hemmersbach R, Cogoli A, Ullrich O: Rapid alterations of cell cycle control proteins in human T lymphocytes in microgravity. Cell Commun Signal 2012;10:1.
102. Hateboer G, Wobst A, Petersen BO, Le Cam L, Vigo E, Sardet C, Helin K: Cell cycle-regulated expression of mammalian CDC6 is dependent on E2F. Mol Cell Biol 1998;18:6679-6697.
103. Yan Z, DeGregori J, Shohet R, Leone G, Stillman B, Nevins JR, Williams RS: Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci USA 1998;95:3603-3608.
104. Feng D, Tu Z, Wu W, Liang C: Inhibiting the expression of DNA replication-initiation proteins induces apoptosis in human cancer cells. Cancer Res 2003;63:7356-7364.
105. Lau E, Zhu C, Abraham RT, Jiang W: The functional role of Cdc6 in S-G2/M in mammalian cells. EMBO Rep 2006;7:425-430.
106. Gillespie PG, Walker RG: Molecular basis of mechanosensory transduction. Nature 2001;413:194-202.
107. Olesen SP, Clapham DE, Davies PF: Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature 1988;331:168-170.
108. Kanzaki M, Nagasawa M, Kojima I, Sato C, Naruse K, Sokabe M, Iida H: Molecular identification of a eukaryotic, stretch-activated nonselective cation channel. Science 1999;285:882-886.
109. Tseng H, Peterson TE, Berk BC: Fluid shear stress stimulates mitogen-activated protein kinase in endothelial cells. Circ Res 1995;77:869-878.
110. Yamazaki T, Tobe K, Hoh E, Maemura K, Kaida T, Komuro I, Tamemoto H, Kadowaki T, Nagai R, Yazaki Y: Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes. J Biol Chem 1993;268:12069-12076.
111. Spisni E, Toni M, Strillacci A, Galleri G, Santi S, Griffoni C, Tomasi V: Caveolae and caveolae constituents in mechanosensing: effect of modeled microgravity on cultured human endothelial cells. Cell Biochem Biophys 2006;46:155-164.
112. Spisni E, Bianco MC, Griffoni C, Toni M, D'Angelo R, Santi S, Riccio M, Tomasi V: Mechanosensing role of caveolae and caveolar constituents in human endothelial cells. J Cell Physiol 2003;197:198-204.
113. Wang N, Butler JP, Ingber DE: Mechanotransduction across the cell surface and through the cytoskeleton. Science 1993;260:1124-1127.
114. Wang N, Ingber DE: Probing transmembrane mechanical coupling and cytomechanics using magnetic twisting cytometry. Biochem Cell Biol 1995;73:327-335
115. Tagawa H, Wang N, Narishige T, Ingber DE, Zile MR, Cooper G 4th: Cytoskeletal mechanics in pressureoverload cardiac hypertrophy. Circ Res 1997;80:281-289.
116. Maniotis AJ, Chen CS, Ingber DE: Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc Natl Acad Sci USA 1997;94:849-854.